Letters by company
LNA Sante SA
7 letters discussing LNA. Everything written about it on this site is on its ticker page.
- Palm Harbour Capital Q4 2022 Letter Palm Harbour Capital added LNA Santé, arguing that its nursing-home business has stronger regulation, lower operating leverage and a different property model than Orpea or Korian. The fund sold Ringmetall on peak-cycle earnings concerns and remains positioned for valuation-driven opportunities amid inflation and rate volatility. fourth quarter 2022 LNA $289M0NEX IBST $429M
- Palm Harbour Capital Letter 2026 Q2 | 687 KB Palm Harbour Capital sold BW Energy and M Dias Branco, added a Mexican cement company and smaller Asian positions, and plans to trade Norma’s buyback rights. It argues that leveraged products and passive flows are distorting Asian markets, while Louis Hachette and Lagardère offer restructuring and ownership-simplification catalysts. second quarter 2026 ALHG $1.9B082920 $961M0NFS
- Palm Harbour Capital Q1 2026 Letter Palm Harbour Capital sold Solvay and Magnum’s, reallocating capital to a Portuguese logistics business and a Korean eyecare company. It argues that Odet’s control structure and Bolloré dividend could enable further consolidation, and makes the case for Cirsa’s regulated gaming franchises, online expansion and acquisition-led growth. first quarter 2026 CIRSA $3.4B082920 $961M0NFS
- Palm Harbour Capital Q2 2024 Letter Piraeus Port Authority anchors a contrarian portfolio case for competitively advantaged assets completing investment programmes while retaining substantial cash and scope for higher dividends. Palm Harbour argues that extreme megacap and AI enthusiasm has widened the opportunity in international value and small caps, while pressing SK Kaken to improve capital allocation. second quarter 2024 0OIY $1.5BGHTI LNA $289M
- Palm Harbour Capital Q4 2023 Letter Palm Harbour Capital increased its Japanese allocation on expectations that stock-exchange pressure will improve capital allocation and shareholder engagement. The fund exited C Uyemura, Bayer and several other positions, while retaining both Solvay and Syensqo after their separation and building exposure to OCI’s asset-sale-driven value realization. fourth quarter 2023 SHBBF $9.1BSVYSF $2.9B4966 $2.2B
- Palm Harbour Capital Q3 2023 Letter Palm Harbour Capital sold Avid Technology after its private-equity takeover and exited Stora Enso over prolonged pulp-market and Chinese-demand concerns. It backs Telekom Austria's tower spin-off, sees OCI's fertilizer assets as undervalued, trimmed C. Uyemura and Verallia, and identifies Ocean Wilsons as a sum-of-the-parts opportunity amid a strategic review of Wilson Sons. third quarter 2023 0NFS 0R5R 4966 $2.2B
- Palm Harbour Capital Q2 2023 Letter Palm Harbour Capital added Lottomatica and three special situations, sold MTU Aero Engines and iHeartMedia, and retained a portfolio of discounted cash-generative securities. It expects strategic actions at IGT and RHI Magnesita, and a higher offer for Treasure ASA, to help unlock value. second quarter of 2023 LOTMY $6.3B086280 $10B0NFS
